Recent studies have shown the superiority of CABG to stenting, in certain subsets of patients with multives-sel coronary disease [1]. This has been particularly true in patients with diabetes mellitus [2]. For those of us who take care of these patients, one always has to consider the worst case scenario. What about the failure mechanism? What if the patient has a graft failure? The recent article by Harskamp et al. [3] brings us pause and is quite sobering.
展开▼
